| {"0": "Alzheimers disease and mirna effects", "1": "Alzheimers disease", "2": "Micrornas in cardiomyocyte hypertrophy", "3": "Mecp2 and associated rett syndrome", "4": "Proteasome degradation", "5": "Electron transport chain oxphos system in mitochondria", "6": "Nonalcoholic fatty liver disease", "7": "Ciliary landscape", "8": "Network map of sarscov2 signaling pathway", "9": "Spinal cord injury", "10": "Overlap between signal transduction pathways contributing to lmna laminopathies", "11": "Hepatitis b infection", "12": "Vitamin d receptor pathway", "13": "Metapathway biotransformation phase i and ii", "14": "Genes related to primary cilium development based on crispr", "15": "Retinoblastoma gene in cancer", "16": "Translation factors", "17": "Oxidative phosphorylation", "18": "Mitochondrial complex i assembly model oxphos system", "19": "G1 to s cell cycle control", "20": "Pi3kakt signaling pathway", "21": "Myometrial relaxation and contraction pathways", "22": "Parkinubiquitin proteasomal system pathway", "23": "Brainderived neurotrophic factor bdnf signaling pathway", "24": "Calcium regulation in cardiac cells", "25": "Cell cycle", "26": "Wnt signaling pathway and pluripotency", "27": "Ncrnas involved in wnt signaling in hepatocellular carcinoma", "28": "Mapk signaling pathway", "29": "Dna replication", "30": "Glycogen synthesis and degradation", "31": "Bladder cancer", "32": "Egfegfr signaling pathway", "33": "Mirna regulation of prostate cancer signaling pathways", "34": "Fragile x syndrome", "35": "Ciliopathies", "36": "Insulin signaling"} |